Personalis receives Medicare coverage for cancer test monitoring

Go back to Personalis receives Medicare coverage for cancer test monitoring
(NASDAQ: PSNL) Delayed: 10.54 +0.79 (8.10%)
Previous Close $9.75    52 Week High
Open $10.00    52 Week Low
Day High $10.58    P/E N/A 
Day Low $9.89    EPS
Volume 3,823,116